• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 405/04 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring- member bond

Patent holdings for IPC class C07D 405/04

Total number of patents in this class: 4172

10-year publication summary

324
357
317
338
343
330
331
335
313
86
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
LG Chem, Ltd.
17205
134
Merck Patent GmbH
5909
133
Novartis AG
11238
58
LT Materials Co., Ltd.
312
52
Janssen Pharmaceutica N.V.
3839
49
Bristol-myers Squibb Company
5080
47
F. Hoffmann-La Roche AG
7958
44
Takeda Pharmaceutical Company Limited
2961
41
Boehringer Ingelheim International GmbH
4629
40
Samsung Display Co., Ltd.
30585
38
The Regents of the University of California
18943
38
Merck Sharp & Dohme LLC
3689
36
Samsung SDI Co., Ltd.
6671
35
FMC Corporation
910
31
Abbvie Inc.
1808
30
Duk San Neolux Co., Ltd.
512
30
Rohm and Haas Electronic Materials Korea Ltd.
546
30
Shaanxi Lighte Optoelectronics Material Co., Ltd.
190
30
AstraZeneca AB
3042
29
Idemitsu Kosan Co., Ltd.
3995
27
Other owners 3220